DEMURTAS, LAURA
 Distribuzione geografica
Continente #
EU - Europa 16.170
NA - Nord America 556
AS - Asia 106
SA - Sud America 1
Totale 16.833
Nazione #
IT - Italia 16.043
US - Stati Uniti d'America 550
CN - Cina 69
SE - Svezia 44
UA - Ucraina 37
SG - Singapore 27
FI - Finlandia 17
GB - Regno Unito 14
DE - Germania 9
CA - Canada 6
IN - India 4
VN - Vietnam 4
FR - Francia 3
BR - Brasile 1
IL - Israele 1
LV - Lettonia 1
NL - Olanda 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 16.833
Città #
Cagliari 15.675
Uta 309
Fairfield 76
Woodbridge 61
Chandler 48
Houston 42
Nyköping 36
Ashburn 34
Boardman 34
Seattle 33
Ann Arbor 28
Dearborn 25
Wilmington 22
Singapore 17
Cambridge 15
Jacksonville 13
Helsinki 12
Santa Clara 12
New York 10
Boston 9
Guangzhou 9
Milan 9
Beijing 8
Shanghai 8
Shenyang 8
Jiaxing 5
Nanjing 5
Toronto 5
Dong Ket 4
San Diego 4
Pune 3
Rome 3
Verona 3
Chicago 2
Hebei 2
London 2
Nanchang 2
Naples 2
Paris 2
Sanluri 2
Washington 2
Wuhan 2
Zhengzhou 2
Baltimore 1
Bergamo 1
Changsha 1
Chiswick 1
Chongqing 1
Foshan 1
Hangzhou 1
Hefei 1
Hounslow 1
Islington 1
Jinan 1
Leawood 1
Lecce 1
Moscow 1
Mountain View 1
Munich 1
New Orleans 1
Orange 1
Ottawa 1
Phoenix 1
Redwood City 1
Riga 1
Sassari 1
Tel Aviv 1
Tianjin 1
Turin 1
Xian 1
Totale 16.632
Nome #
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.078
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.512
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded? 2.152
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.068
The immune revolution in gastrointestinal tumours: leading the way or just following? 1.868
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 1.480
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors 1.272
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 671
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 413
Clinical Outcome of Patients With Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment 139
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 127
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 94
Totale 16.874
Categoria #
all - tutte 20.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.791 0 0 0 0 0 1.006 508 73 49 40 32 83
2020/20213.868 99 158 117 1.365 777 441 216 197 73 184 147 94
2021/2022656 64 36 47 35 29 50 36 41 48 61 61 148
2022/20231.040 112 188 128 78 79 86 42 86 59 68 61 53
2023/20241.226 64 55 37 79 113 175 240 104 82 81 99 97
2024/20252.548 858 856 261 291 162 120 0 0 0 0 0 0
Totale 16.874